<article id="weyckler_2009_p" class="slide" data-ag-slide-name="Weyckler 2009 (P)">
    <div class="basic">
      <h1 data-ag-editable="Weycker 2009 (P) Main Title">Neulasta<sup>®</sup> just once per cycle* provides a tailored way to reduce the risk of neutropenia-related hospitalisation compared with filgrastim<sup>1</sup></h1>
      <!--<div id="fn_page3_graph1_p" class="main_content_style">
         <img src="content/images/pragmatist_pages/burden_of_fn/page3_graph1.png" width="540" height="361" data-ag-editable="Weycker 2009 (P) Main Graph" />
          <div id="weyckler_2009_p_graph_content">
              <h2 id="table_header_1" data-ag-editable="Weycker 2009 (P) Graph Header 1">hospitalization</h2>
              <h2 id="table_header_2" data-ag-editable="Weycker 2009 (P) Graph Header 2">odds-ratio <br/>(95% KI)</h2>
              <h2 id="table_header_3" data-ag-editable="Weycker 2009 (P) Graph Header 3">p</h2>
              <h2 id="table_header_4" data-ag-editable="Weycker 2009 (P) Graph Header 4">odds-ratio <br/>(95% KI)</h2>
              <p id="cell_1" data-ag-editable="Weycker 2009 (P) Graph Cell 1">Patients hospitalized<br/> with neutropenia<br/>(narrow criterion)<sup>†</sup></p>
              <p id="cell_2" data-ag-editable="Weycker 2009 (P) Graph Cell 2">0.64<br/>(0.41 - 0.99)</p>
              <p id="cell_3" data-ag-editable="Weycker 2009 (P) Graph Cell 3">0.043</p>
              <p id="cell_4" data-ag-editable="Weycker 2009 (P) Graph Cell 4">Patients hospitalized<br/> with neutropenia,<br/>fever or infection<br/>(broad criterion)<sup>‡</sup></p>
              <p id="cell_5" data-ag-editable="Weycker 2009 (P) Graph Cell 5">0.69<br/>(0.52 - 0.92)</p>
              <p id="cell_6" data-ag-editable="Weycker 2009 (P) Graph Cell 6">0.012</p>
              <ul id="graph_scale_values" data-ag-editable="Weycker 2009 (P) Graph Scale Values">
                  <li>0</li>
                  <li>0.5</li>
                  <li>1.0</li>
                  <li>1.5</li>
                  <li>2.0</li>
              </ul>
              <p id="left_arrow_text" data-ag-editable="Weycker 2009 (P) Graph Left Arrow Text">Favours Neulasta<sup>®</sup></p>
              <p id="right_arrow_text" data-ag-editable="Weycker 2009 (P) Graph Right Arrow Text">Favours Daily filgrastim</p>
              <p id="bottom_text" data-ag-editable="Weycker 2009 (P) Graph Bottom Text">Adapted from Weyckler D <span class="et_al">et al.</span> Clin Ther 2009; 31(5);1069-1081</p>
          </div>
      </div>-->
        
      <div id="weyckler_2009_p_graph_holder">
         <div id="weyckler_2009_p_large" class="main_content_style">
             <img src="content/images/pragmatist_pages/burden_of_fn/page3_graph1_large.png" width="807" height="495" data-ag-editable="Weycker 2009 (P) Graph Background" />
             <div id="weyckler_2009_p_graph_content_large">
                 <h2 id="table_header_1_large" data-ag-editable="Weycker 2009 (P) Graph Header 1">hospitalisation</h2>
                 <h2 id="table_header_2_large" data-ag-editable="Weycker 2009 (P) Graph Header 2">odds-ratio <br/>(95% KI)</h2>
                 <h2 id="table_header_3_large" data-ag-editable="Weycker 2009 (P) Graph Header 3">p</h2>
                 <h2 id="table_header_4_large" data-ag-editable="Weycker 2009 (P) Graph Header 4">odds-ratio <br/>(95% KI)</h2>
                 <p id="cell_1_large" data-ag-editable="Weycker 2009 (P) Graph Cell 1">Patients hospitalised<br/> with neutropenia<br/>(narrow criterion)<sup>†</sup></p>
                 <p id="cell_2_large" data-ag-editable="Weycker 2009 (P) Graph Cell 2">0.64<br/>(0.41 - 0.99)</p>
                 <p id="cell_3_large" data-ag-editable="Weycker 2009 (P) Graph Cell 3">0.043</p>
                 <p id="cell_4_large" data-ag-editable="Weycker 2009 (P) Graph Cell 4">Patients hospitalised<br/> with neutropenia,<br/>fever or infection<br/>(broad criterion)<sup>‡</sup></p>
                 <p id="cell_5_large" data-ag-editable="Weycker 2009 (P) Graph Cell 5">0.69<br/>(0.52 - 0.92)</p>
                 <p id="cell_6_large" data-ag-editable="Weycker 2009 (P) Graph Cell 6">0.012</p>
                 <ul id="graph_scale_values_large" data-ag-editable="Weycker 2009 (P) Graph Scale Values">
                     <li>0</li>
                     <li>0.5</li>
                     <li>1.0</li>
                     <li>1.5</li>
                     <li>2.0</li>
                 </ul>
                 <p id="left_arrow_text_large" data-ag-editable="Weycker 2009 (P) Graph Left Arrow Text">Favours Neulasta<sup>®</sup></p>
                 <p id="right_arrow_text_large" data-ag-editable="Weycker 2009 (P) Graph Right Arrow Text">Favours Daily filgrastim</p>
                 
                 <p id="bottom_text_large" data-ag-editable="Weycker 2009 (P) Graph Bottom Text">Adapted from Weyckler D <span class="et_al">et al.</span> Clin Ther 2009; 31(5);1069-1081
                     <br />
                     <br />
                     Hospitalisation for neutropenic complications (narrow criterion) was 2.1% with daily filgrastim and 1.2% with Neulasta; hospitalisation for neutropenia, fever or infection (broad criterion) was 4.8% with daily filgrastim and 3.1% with Neulasta
                 </p>
             </div>
         </div>
      </div>
      <div id="fn_page3_data_top_p">
        <ul class="red_dot_list" data-ag-editable="Weycker 2006 (P) Top List Copy">
           <li>Risks of hospitalisation for neutropenic complications of chemotherapy in clinical practice: 36% less likely with Neulasta<sup>®</sup> compared to daily filgrastim<sup>1</sup></li>
        </ul>
      </div>
    </div>
    <!-- Reference Information Starts -->
    <div class="enlarge_graph" id="enlarge_graph_weyckler_2009_p"></div>
    <div class="lightbox_data" id="weyckler_2009_p_refs">
       <div class="main_content_style">
          <p><strong data-ag-editable="Weycker 2009 (P) References Title">References:</strong></p>
          <div data-ag-editable="Weycker 2009 (P) References List">
             <ol>
                <li>Weycker D <em>et al</em>. Risk of Hospitalisation for Neutropenic Complications of Chemotherapy in Patients With Primary Solid Tumors Receiving Pegfilgrastim or Filgrastim Prophylaxis: A Retrospective Cohort Study. Clin Ther 2009; 31(5):1069-1081</li>
             </ol>
          </div>
          <p data-ag-editable="Weycker 2009 (P) References Bottom Copy">* 24 hours after chemotherapy. <br /><br />
          † Hospital admission with a diagnosis (primary or secondary) of neutropenia. <br /><br />
          ‡ Hospital admission with a diagnosis (primary or secondary) of neutropenia, fever, or infection Retrospective cohort study of 4903 patients with breast, Non-Hodgkin’s Lymphoma, lung and other malignancies. Data were obtained from US medical and claim databases from 15,763 patients who received a course of chemotherapy between 2003 and 2005 and had a medical or pharmacy claim for pegfilgrastim or filgrastim at any time.</p>
       </div>
    </div>
    <!-- Reference Information Ends -->
</article>